Concomitant antigen-specific CD8 and CD4 T cell responses were also observed upon vaccination with the Melan-A26–35 peptide that triggered a switch from Treg to Th1 polarized tumor-specific CD4 T cells in HLA-DQ6-vaccinated melanoma patients [58]. Here, CD8A is linked to neoplasm.